Trademark: 85090572
Word

Status
Registered
Status Code
800
Status Date
Saturday, December 3, 2022
Serial Number
85090572
Registration Number
4177724
Registration Date
Tuesday, July 24, 2012
Mark Type
2000
Filing Date
Thursday, July 22, 2010
Published for Opposition
Tuesday, May 8, 2012

Trademark Owner History

Classifications
5 Medicines for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; traditional Chinese medicines in the nature of Chinese patent medicines for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; pharmaceutical preparations and medicinal herbs all for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; raw medicines, namely, raw materials pharmaceuticals, namely, medicinal herbal extracts for medical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry; biological preparations for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; medicines for the treatment of pain in the gums and periodontia; sanitary sterilizing preparations, namely, disinfectants for medical instruments and medical cleansers for skin and wounds; solutions for contact lenses; dietetic foods adapted for medical purposes and nutritional additives for medical purposes, namely, vitamins, ginseng for medicinal use and royal jelly for medical use; dietetic food preparations adapted for medical purposes, namely, dietary and nutritional supplements, nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, all for treatment of trace element deficiency; infant formula, namely, infant milk powder; air purifying preparations; veterinary preparations, namely, veterinary vaccines for anti-inflammation and pain relief; pesticides; herbicides; sanitary towels; sterile paper towel, namely, medicated pre-moistened towelettes; sticking plasters for medical purposes; medical adhesive tape; medical dressings, namely, gauze and cotton for medical purposes; surgical dressings; surgical tissues, namely, hygienic bandages; first-aid kits; fillings for teeth
The mark consists of the two Chinese characters Wen Xin.
In the statement, Column 1, line 1, Shandong Buchang Pharmaceutical Incorporated Company No. 369, Zhonghua West Road Shandong Province China should be inserted
In the statement, Column 1, after line 2, Heze City should be inserted.
Color is not claimed as a feature of the mark.
The non-Latin characters in the mark transliterate to "WEN XIN" and this means nothing in English.

Trademark Events
Dec 3, 2022
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Dec 3, 2022
Registered And Renewed (First Renewal - 10 Yrs)
Dec 3, 2022
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Dec 3, 2022
Case Assigned To Post Registration Paralegal
May 19, 2022
Teas Section 8 & 9 Received
May 12, 2022
Teas Change Of Correspondence Received
May 12, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
May 12, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 12, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 24, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Nov 12, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 12, 2020
Teas Change Of Correspondence Received
Nov 12, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 12, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 12, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 12, 2020
Teas Change Of Owner Address Received
Jan 29, 2019
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 29, 2019
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 28, 2019
Teas Response To Office Action-Post Reg Received
Jul 30, 2018
Post Registration Action Mailed - Sec. 8 & 15
Jul 26, 2018
Case Assigned To Post Registration Paralegal
Jul 17, 2018
Teas Section 8 & 15 Received
Jul 24, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 11, 2016
Correction Under Section 7 - Processed
Jan 11, 2016
Case Assigned To Post Registration Paralegal
Dec 21, 2015
Teas Section 7 Request Received
Dec 21, 2015
Teas Change Of Correspondence Received
Jul 22, 2014
Correction Under Section 7 - Processed
Dec 2, 2013
Case Assigned To Post Registration Paralegal
Oct 1, 2013
Otqr Withdrawal From Publication
Sep 13, 2013
New Certificate Under Section 7 - Processed
Aug 26, 2013
Request For New Certificate Filed
Sep 13, 2013
Case Assigned To Post Registration Paralegal
Aug 26, 2013
Teas Section 7 Request Received
Jul 24, 2012
Registered-Principal Register
May 30, 2012
Assignment Of Ownership Not Updated Automatically
May 8, 2012
Official Gazette Publication Confirmation E-Mailed
May 8, 2012
Published For Opposition
Apr 18, 2012
Notification Of Notice Of Publication E-Mailed
Apr 4, 2012
Law Office Publication Review Completed
Mar 29, 2012
Assigned To Lie
Mar 24, 2012
Approved For Pub - Principal Register
Feb 27, 2012
Teas/Email Correspondence Entered
Feb 27, 2012
Correspondence Received In Law Office
Feb 27, 2012
Teas Request For Reconsideration Received
Oct 9, 2011
Notification Of Final Refusal Emailed
Oct 9, 2011
Final Refusal E-Mailed
Oct 9, 2011
Final Refusal Written
Sep 19, 2011
Examiner's Amendment Entered
Sep 18, 2011
Assigned To Lie
Sep 18, 2011
Notification Of Examiners Amendment E-Mailed
Sep 18, 2011
Examiners Amendment E-Mailed
Sep 18, 2011
Examiners Amendment -Written
Aug 22, 2011
Teas/Email Correspondence Entered
Aug 22, 2011
Correspondence Received In Law Office
Aug 22, 2011
Teas Response To Office Action Received
Jun 4, 2011
Notification Of Non-Final Action E-Mailed
Jun 4, 2011
Non-Final Action E-Mailed
Jun 4, 2011
Non-Final Action Written
May 10, 2011
Teas/Email Correspondence Entered
May 9, 2011
Correspondence Received In Law Office
May 9, 2011
Teas Response To Office Action Received
Nov 10, 2010
Notification Of Non-Final Action E-Mailed
Nov 10, 2010
Non-Final Action E-Mailed
Nov 10, 2010
Non-Final Action Written
Nov 4, 2010
Assigned To Examiner
Jul 28, 2010
Notice Of Design Search Code Mailed
Jul 27, 2010
New Application Office Supplied Data Entered
Jul 26, 2010
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24